MindBio Therapeutics Corp. (CSE:MBIO)

Canada flag Canada · Delayed Price · Currency is CAD
1.100
-0.050 (-4.35%)
Apr 10, 2026, 3:58 PM EST
Market Cap8.01M +180.2%
Revenue (ttm)n/a
Net Income-5.49M
EPS-0.01
Shares Out7.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume11,569
Open1.100
Previous Close1.150
Day's Range1.080 - 1.100
52-Week Range0.500 - 6.000
Beta-1.51
RSI50.13
Earnings DateMay 13, 2026

About MindBio Therapeutics

MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for developing novel and clinically proven treatments for de... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MBIO
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements

News

MindBio Announces Closing of Private Placement

Vancouver, British Columbia – April 1, 2026 – TheNewswire -  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF)  (the “ Company ” or “ MindBio ”), a biotechnology company that is ...

9 days ago - TheNewswire

MindBio Announces Upsize to Private Placement up to $1.5 Million

Vancouver, British Columbia –  TheNewswire - March 19, 2026  –  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF),  (the “ Company ” or “ MindBio ”), a biotechnology company comm...

23 days ago - TheNewswire

MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation

Vancouver, British Columbia – TheNewswire - February 24, 2026 – MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) (“MindBio” or the “Company”), a biotechnology innovator commercia...

6 weeks ago - TheNewswire

MindBio Announces Private Placement to Raise up to $650,000

Vancouver, British Columbia -  TheNewswire - February 18, 2026  –  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF),  (the “ Company ” or “ MindBio ”), a biotechnology company t...

7 weeks ago - TheNewswire

MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF) (“MindBio” or the “Company”) , a biotechnology company commercial...

7 weeks ago - TheNewswire

MindBio Deploys Engineers to South American Mining Industry, Accelerates Investment in Enterprise Voice AI Health Diagnostics.

Vancouver, British Columbia – TheNewswire - February 4, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), is pleased to report following it...

2 months ago - TheNewswire

MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution

CEO Meets with Mining and Health Executives in South America to discuss deployment of new drug and alcohol screening solution.  Mining deployment of the technology would disrupt drug and alcohol testi...

2 months ago - TheNewswire

MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology

Vancouver, British Columbia – TheNewswire - January 27, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that cond...

2 months ago - TheNewswire

MindBio Showcases World First Voice AI Intoxication Detection Technology in USA. Targets Health Diagnostics Market with Exciting New Technology

Vancouver, British Columbia – TheNewswire - January 2 1 , 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that co...

2 months ago - TheNewswire

MindBio Lists for Trading on OTCQB Market

Vancouver, British Columbia – TheNewswire - January 21, 202 6 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that con...

2 months ago - TheNewswire